TrialGastroenterology2018

GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease.

Rohit Loomba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.